CHANGING THE WAY WE DIAGNOSE DISEASES
TIME-CRITICAL DIAGNOSTICS

ALiA brings a paradigm shift on time-critical diagnostics by combining revolutionary technology into a compact, easy-to-use package.

LAB-ON-CHIP

A Lab-On-Chip (LOC) is a small device that integrates one or several laboratory functions on a single chip of only millimetres to a few square centimetres in size. LOC deals with the handling of extremely small fluid volumes.

 

​Sanwa BioTech develops self-contained LOC diagnostic platforms such as ALiA, Ariel, Thetis. Each of these platforms is a miniaturized solution that consists of microfluidic program, optical units, control units and individual power supply system, which can run microfluidic chip without any fluidic interfaces to the instrument. The integrated BioChip is embedded 6 liquid reservoirs with individual micropumps, where the test reagents and specimen are loaded, to control and process all the liquids to test area. 

FLUORESCENT IMMUNOASSAY

Immunoassay is a biochemical test that measures the presence or concentration of a macromolecule in a solution through the use of an antibody or antigen. The macromolecule detected by the immunoassay is in many cases a protein. The importance and widespread of immunoassay methods in diagnosis of diseases are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of wide range of analytes in biological samples. ​

 

By combining microfluidics to immunoassay, Sanwa BioTech’s platform speeds up the test process and empower the test with multiplex functions while keeping the specificity and sensitivity of immunoassay in a lab. This system permits healthcare providers in limited equipped clinics to perform diagnostic tests with free laboratory support.

MICROARRAY

The technology of protein microarray is to print and incubate specific proteins and peptides onto a chemical processed glass slide in extremely small scale. Combining with the microfluidic chip, the microarray will capture the target antigen or antibody from the specimen to complete the fluorescent immunoassay. This microarray enables the platform to perform multiplex immunoassay at one test within 15 minutes.

PATENTS

Sanwa Biotech holds 15 patents, 5 design patents and 19 trademarks to protect our intellectual property.   ​The Point-Of-Care platform ALiA is protected by patents in worldwide.  

 

​These platforms provide methods for identifying the presence of multiple diseases in a specimen. Also, the microfluidic system coupled with the immunoassay allows rapid diagnostics and increases the quality of patients care.

© 2019 by Sanwa BioTech